Cargando…
Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
BACKGROUND: The Tumor Location-Modified Laurén Classification (MLC) system combines Laurén histologic subtype and anatomic tumor location. It divides gastric tumors into proximal non-diffuse (PND), distal non-diffuse (DND), and diffuse (D) types. The optimum classification of patients with Laurén mi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072452/ https://www.ncbi.nlm.nih.gov/pubmed/35041098 http://dx.doi.org/10.1245/s10434-021-11252-y |
_version_ | 1784701064593801216 |
---|---|
author | Moore, J. L. Davies, A. R. Santaolalla, A. Van Hemelrijck, M. Maisey, N. Lagergren, J. Gossage, J. A. Kelly, M. Baker, C. R. |
author_facet | Moore, J. L. Davies, A. R. Santaolalla, A. Van Hemelrijck, M. Maisey, N. Lagergren, J. Gossage, J. A. Kelly, M. Baker, C. R. |
author_sort | Moore, J. L. |
collection | PubMed |
description | BACKGROUND: The Tumor Location-Modified Laurén Classification (MLC) system combines Laurén histologic subtype and anatomic tumor location. It divides gastric tumors into proximal non-diffuse (PND), distal non-diffuse (DND), and diffuse (D) types. The optimum classification of patients with Laurén mixed tumors in this system is not clear due to its grouping with both diffuse and non-diffuse types in previous studies. The clinical relevance of the MLC in a Western population has not been examined. METHODS: A cohort study investigated 404 patients who underwent gastrectomy for gastric adenocarcinoma between 2005 and 2020. The classification of Laurén mixed tumors was evaluated using receiver operating characteristic (ROC) curve analysis and comparison of clinicopathologic characteristics (chi-square). Survival analysis was performed using multivariable Cox regression. RESULTS: The ROC curve analysis demonstrated a slightly higher area under the curve value for predicting survival when Laurén mixed tumors were grouped with intestinal-type rather than diffuse-type tumors (0.58 vs 0.57). Survival, tumor recurrence, and resection margin positivity in mixed tumors also was more similar to intestinal type. Distal non-diffuse tumors had the best 5-year survival (DND 64.7 % vs PND 56.1 % vs diffuse 45.1 %; p = 0.006) and were least likely to have recurrence (DND 27.0 % vs PND 34.3 % vs diffuse 48.3 %; p = 0.001). Multivariable analysis demonstrated that MLC was an independent prognostic factor for survival (PND: hazard ratio [HR], 1.64; 95 % confidence interval [CI], 1.16–2.32 vs diffuse: HR, 2.20; 95 % CI, 1.56–3.09) CONCLUSIONS: The MLC was an independent prognostic marker in this Western cohort of patients with gastric adenocarcinoma. The patients with PND and D tumors had worse survival than those with DND tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-021-11252-y. |
format | Online Article Text |
id | pubmed-9072452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-90724522022-05-07 Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population Moore, J. L. Davies, A. R. Santaolalla, A. Van Hemelrijck, M. Maisey, N. Lagergren, J. Gossage, J. A. Kelly, M. Baker, C. R. Ann Surg Oncol Gastrointestinal Oncology BACKGROUND: The Tumor Location-Modified Laurén Classification (MLC) system combines Laurén histologic subtype and anatomic tumor location. It divides gastric tumors into proximal non-diffuse (PND), distal non-diffuse (DND), and diffuse (D) types. The optimum classification of patients with Laurén mixed tumors in this system is not clear due to its grouping with both diffuse and non-diffuse types in previous studies. The clinical relevance of the MLC in a Western population has not been examined. METHODS: A cohort study investigated 404 patients who underwent gastrectomy for gastric adenocarcinoma between 2005 and 2020. The classification of Laurén mixed tumors was evaluated using receiver operating characteristic (ROC) curve analysis and comparison of clinicopathologic characteristics (chi-square). Survival analysis was performed using multivariable Cox regression. RESULTS: The ROC curve analysis demonstrated a slightly higher area under the curve value for predicting survival when Laurén mixed tumors were grouped with intestinal-type rather than diffuse-type tumors (0.58 vs 0.57). Survival, tumor recurrence, and resection margin positivity in mixed tumors also was more similar to intestinal type. Distal non-diffuse tumors had the best 5-year survival (DND 64.7 % vs PND 56.1 % vs diffuse 45.1 %; p = 0.006) and were least likely to have recurrence (DND 27.0 % vs PND 34.3 % vs diffuse 48.3 %; p = 0.001). Multivariable analysis demonstrated that MLC was an independent prognostic factor for survival (PND: hazard ratio [HR], 1.64; 95 % confidence interval [CI], 1.16–2.32 vs diffuse: HR, 2.20; 95 % CI, 1.56–3.09) CONCLUSIONS: The MLC was an independent prognostic marker in this Western cohort of patients with gastric adenocarcinoma. The patients with PND and D tumors had worse survival than those with DND tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-021-11252-y. Springer International Publishing 2022-01-18 2022 /pmc/articles/PMC9072452/ /pubmed/35041098 http://dx.doi.org/10.1245/s10434-021-11252-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Gastrointestinal Oncology Moore, J. L. Davies, A. R. Santaolalla, A. Van Hemelrijck, M. Maisey, N. Lagergren, J. Gossage, J. A. Kelly, M. Baker, C. R. Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population |
title | Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population |
title_full | Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population |
title_fullStr | Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population |
title_full_unstemmed | Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population |
title_short | Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population |
title_sort | clinical relevance of the tumor location-modified laurén classification system for gastric cancer in a western population |
topic | Gastrointestinal Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072452/ https://www.ncbi.nlm.nih.gov/pubmed/35041098 http://dx.doi.org/10.1245/s10434-021-11252-y |
work_keys_str_mv | AT moorejl clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT daviesar clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT santaolallaa clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT vanhemelrijckm clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT maiseyn clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT lagergrenj clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT gossageja clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT kellym clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT bakercr clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation AT clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation |